title: Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not?
authors.forename: A R
authors.initials: AR
authors.lastname: Clewes
authors.forename: E J
authors.initials: EJ
authors.lastname: Tunn
authors.forename: S
authors.initials: S
authors.lastname: Kaye
authors.forename: R C
authors.initials: RC
authors.lastname: Bucknall
mesh_terms: D000368:Aged; D001172:Arthritis, Rheumatoid / Q000150:complications; D003320:Corneal Ulcer / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide